ClinVar Miner

Submissions for variant NM_000162.5(GCK):c.659G>A (p.Cys220Tyr)

dbSNP: rs193922316
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000029903 SCV000052558 likely pathogenic Maturity-onset diabetes of the young type 2 2011-08-18 criteria provided, single submitter clinical testing Converted during submission to Likely pathogenic.
Ambry Genetics RCV002371786 SCV002667188 likely pathogenic Maturity onset diabetes mellitus in young 2016-01-20 criteria provided, single submitter clinical testing The p.C220Y variant (also known as c.659G>A), located in coding exon 6 of the GCK gene, results from a G to A substitution at nucleotide position 659. The cysteine at codon 220 is replaced by tyrosine, an amino acid with highly dissimilar properties. This variant was reported in a proband and her mother who were both affected with glucose intolerance (Shoemaker AH et al, Diabetes Res. Clin. Pract. 2012 May; 96(2):e36-9). Mutant mice carrying this variant showed reduced protein expression and activity, as well as impaired glucose intolerance (Inoue M et al, Hum. Mol. Genet. 2004 Jun; 13(11):1147-57). This variant was previously reported in the SNPDatabase as rs193922316. This variant was not reported in population based cohorts the following database: NGLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. An alteration at the same amino acid position, p.C220R (c.658T>C), was described in homozygous state in two sibling with permanent neonatal diabetes mellitus (Demirbilek H et al, Eur. J. Endocrinol. 2015 Jun; 172(6):697-705). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
GeneDx RCV004721247 SCV005327230 likely pathogenic not provided 2024-03-20 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22341229, 37008541, 31957151, 15102714, 22341299, 25755231)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.